European Agencies Readying Draft Guidance For Identifying Endocrine Disruptors
This article was originally published in The Rose Sheet
Executive Summary
Regulatory movement to define endocrine disruptors for identification purposes hasn't had any direct impact on cosmetics yet, but the EC is required to review the Cosmetics Directive with respect to endocrine-disrupting substances once criteria have been established, a target that may be in sight.
You may also be interested in...
CIR News In Brief: No Conclusion Reached On PHMB; Endocrine Activity Guidance; More
At its Sept. 11-12 meeting in Washington, the Cosmetic Ingredient Review Expert Panel finalized reports for various protein and peptide ingredient families, among others, and advanced six tentative reports. The panel issued a tentative insufficient data conclusion for broad-spectrum preservative polyaminopropyl biguanide, with concerns about sensitization continuing to weigh on the group.
EC Releases Endocrine-Disruptor Criteria, Drawing Heavily On WHO Definitions
The European Commission’s newly released criteria for identifying endocrine disruptors in the plant-protection and biocidal product sectors have no direct regulatory impact on cosmetics, but could signal the approach the EC will take in other areas as it works to manage endocrine-disruptor risks. A review of the Cosmetics Regulation’s applicability to endocrine disruptors is nearing completion, the EC says.
Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat
Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.